InSphero Company
InSphero is a supplier of organotypic, biological, in vitro 3D microtissues for highly predictive drug testing.
Technology:
COVID, Organoids
Industry:
AgeTech, Providers
Headquarters:
Schlieren, Zurich, Switzerland
Founded Date:
2009-01-01
Employees Number:
11-50
Funding Status:
Late Stage Venture
Investors Number:
7
Total Funding:
35182726
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019-03-19
Last Funding Type:
Grant
Register and Claim Ownership